CD34 and Friedreich ataxia: These results, together with the observation that a high percentage of patients with FA with NKG2D-L–overexpressing CD34+ cells showed clinical signs of BMF, further support the relevance of NKG2D-L expression in the pathogenesis of BMF in FA.